The Seventh National Lesbian/Gay Health Conference and Fourth National AIDS Forum will be held March 13-16, 1986, at George Washington University, Washington, D.C., sponsored by the National Lesbian and Gay Health Foundation, Inc.
MMWR Weekly, December 06, 1985 / 34(48);721-6,731-2
The information and recommendations in this document are intended to assist health-care providers and state and local health departments in developing procedures to prevent perinatal transmission of human T-lympho- tropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV), the virus that causes acquired immunodeficiency syndrome (AIDS).
MMWR Weekly, November 15, 1985 / 34(45);682-6,691-5
Persons at increased risk of acquiring infection with human T-lympho- tropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV), the virus that causes acquired immunodeficiency syndrome (AIDS), include homosexual and bisexual men, intravenous (IV) drug abusers, persons transfused with contaminated blood or blood products, heterosexual contacts of persons with HTLV-III/LAV infection, and children born to infected mothers.
The information and recommendations contained in this document have been developed with particular emphasis on health-care workers and others in related occupations in which exposure might occur to blood from persons infected with HTLV-III/LAV, the "AIDS virus."
Following a consultation on acquired immunodeficiency syndrome (AIDS) in April 1985, the World Health Organization (WHO) established a network of Collaborating Centres on AIDS to provide a framework for international cooperation, including training, provision of reference reagents, evaluation of methods, and epidemiologic surveillance.
Between 1978 and 1980, a cohort of approximately 6,875 homosexual and bisexual men who had sought evaluation for sexually transmitted diseases at the San Francisco (California) City Clinic was enrolled in a series of studies of the prevalence, incidence, and prevention of hepatitis B virus infections.
Acquired immunodeficiency syndrome (AIDS) is caused by a virus that is known to be transmitted through sexual contact and parenteral exposure to blood or blood products and from mother to child during the perinatal period.
MMWR Weekly - June 07, 1985 / 34(22);313-24,329-35
The term "viral hepatitis" is commonly used for several clinically similar diseases that are etiologically and epidemiologically distinct (1). Two of these, hepatitis A (formerly called infectious hepatitis) and hepatitis B (formerly called serum hepatitis) have been recognized as separate entities since the early 1940s and can be diagnosed with specific serologic tests.
The U.S. Public Health Service has recommended that all donated blood and plasma be tested for antibody to human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV), the virus that causes acquired immunodeficiency syndrome (AIDS) (1). It is additionally recommended that blood or serum from donors of organs, tissues, or semen intended for human use be similarly tested and that the test result be used to evaluate the appropriate use of such materials from these donors.
In December 1982, Kaposi's sarcoma and acquired immunodeficiency syndrome (AIDS) were diagnosed in a 29-year-old white homosexual man. A trial of vinblastine sulfate failed to decrease the progression of his skin lesions. In February 1984, when seen in a clinic in Tijuana, Mexico, he was given a BCG vaccination. The expected local lesion from the BCG vaccination healed normally within the next few weeks.
In March 1983, the U.S. Public Health Service issued inter-agency recommendations on the prevention of acquired immunodeficiency syndrome (AIDS) (1). Included was the recommendation that members of groups at increased risk for AIDS should refrain from donating plasma and/or blood.
This information is designed to support, not replace, the relationship that exists between you and your doctor.